Best Biotechnology Stocks

Compare the best biotech stocks to buy today.

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	PE Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$192.99 -0.3%	57.27	$340.79 billion	4.42 million	5.33 million	Analyst Forecast
TMO Thermo Fisher Scientific	$595.14 -0.6%	38.17	$227.17 billion	883,538	1.47 million
DHR Danaher	$268.81 +0.0%	45.56	$199.10 billion	1.43 million	2.74 million
VRTX Vertex Pharmaceuticals	$458.94 +2.3%	29.78	$118.45 billion	1.32 million	1.18 million	Analyst Forecast
GSK GSK	$38.03 -1.6%	13.78	$78.82 billion	4.63 million	3.60 million
TAK Takeda Pharmaceutical	$14.29 -0.3%	25.98	$45.23 billion	2.09 million	1.87 million
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
COR Cencora	$220.80 +0.6%	24.16	$44.04 billion	1.60 million	1.42 million	Analyst Forecast Analyst Revision
IQV IQVIA	$226.78 +0.6%	30.98	$41.34 billion	885,110	1.08 million	Analyst Forecast Analyst Revision
CTSH Cognizant Technology Solutions	$76.13 +0.2%	18.30	$37.85 billion	2.76 million	3.88 million	Positive News
ALNY Alnylam Pharmaceuticals	$271.19 +1.7%	N/A	$33.74 billion	620,984	870,567	Analyst Revision
VEEV Veeva Systems	$204.44 +1.3%	60.31	$33.10 billion	650,143	958,587	Analyst Forecast
ARGX argenx	$527.16 +0.8%	N/A	$31.07 billion	333,970	316,378
BNTX BioNTech	$120.30 -1.0%	240.60	$28.60 billion	524,679	794,598	Analyst Forecast
ICLR ICON Public	$287.56 -1.0%	34.98	$23.72 billion	525,616	575,536	Analyst Forecast Analyst Revision News Coverage
MRNA Moderna	$58.39 -0.6%	N/A	$22.38 billion	3.82 million	4.34 million
ILMN Illumina	$139.66 -0.7%	N/A	$22.25 billion	2.27 million	2.03 million	Positive News
DNA Ginkgo Bioworks	$8.34 -0.2%	N/A	$18.44 billion	531,867	1.16 million	Positive News
LH Laboratory Co. of America	$212.66 +0.3%	42.79	$17.93 billion	297,275	668,876	Analyst Downgrade Analyst Revision
RPRX Royalty Pharma	$27.36 -0.8%	20.42	$16.24 billion	1.59 million	2.63 million	Positive News
UTHR United Therapeutics	$355.79 +1.7%	16.82	$15.78 billion	226,254	478,589	Insider Selling Positive News
RVTY Revvity	$122.03 -0.4%	100.85	$15.06 billion	439,851	823,147	Positive News
SUZ Suzano	$10.05 -1.5%	7.18	$13.31 billion	1.08 million	1.86 million	Gap Down
PCVX Vaxcyte	$111.75 +3.0%	N/A	$12.47 billion	616,249	846,599	Positive News
CTLT Catalent	$60.75 +0.2%	N/A	$10.99 billion	673,863	2.07 million
MEDP Medpace	$338.16 +1.7%	34.47	$10.30 billion	279,985	263,807	News Coverage
CRL Charles River Laboratories International	$186.83 -1.3%	21.98	$9.62 billion	718,215	597,642	Analyst Downgrade
BIO.B Bio-Rad Laboratories	$334.85	N/A	$9.55 billion	8	985	Positive News
FN Fabrinet	$244.99 +1.1%	32.54	$8.86 billion	208,921	483,455	Positive News
LEGN Legend Biotech	$48.06 -3.1%	N/A	$8.76 billion	643,873	1.02 million	Analyst Forecast Gap Up
IBB iShares Biotechnology ETF	$143.00 +0.6%	N/A	$7.46 billion	608,470	1.49 million	News Coverage
KRYS Krystal Biotech	$174.84 -0.1%	93.50	$4.99 billion	116,526	343,809	Positive News
LITE Lumentum	$67.75 +0.7%	N/A	$4.58 billion	1.08 million	1.42 million
DNLI Denali Therapeutics	$26.73 +0.5%	N/A	$3.79 billion	557,363	1.12 million	Analyst Downgrade News Coverage
TGTX TG Therapeutics	$21.84 +2.5%	94.96	$3.38 billion	2.24 million	3.72 million	Positive News
APGE Apogee Therapeutics	$56.11 +1.6%	N/A	$3.28 billion	150,394	514,122
HTGC Hercules Capital	$20.16 +0.7%	9.16	$3.25 billion	433,017	930,416	Positive News
FOLD Amicus Therapeutics	$10.04 -1.8%	N/A	$2.97 billion	2.61 million	2.73 million	Analyst Upgrade Analyst Revision News Coverage
DYN Dyne Therapeutics	$33.13 +4.6%	N/A	$2.89 billion	844,482	1.57 million
IOVA Iovance Biotherapeutics	$9.72 -2.7%	N/A	$2.80 billion	3.64 million	7.33 million
TWST Twist Bioscience	$42.54 +0.9%	N/A	$2.49 billion	414,345	980,334	Positive News
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now
AZTA Azenta	$45.69 -3.3%	N/A	$2.46 billion	390,489	501,473
IBRX ImmunityBio	$3.52 +0.9%	N/A	$2.43 billion	1.18 million	4.54 million	News Coverage
TXG 10x Genomics	$20.11 +1.4%	N/A	$2.42 billion	954,616	1.61 million
SWTX SpringWorks Therapeutics	$32.41 +0.4%	N/A	$2.40 billion	954,586	964,296
BE Bloom Energy	$10.24 -1.2%	N/A	$2.32 billion	2.85 million	5.88 million	Positive News
ODD Oddity Tech	$39.69 -0.6%	33.08	$2.26 billion	103,952	717,846	Positive News
SXI Standex International	$181.61	29.39	$2.13 billion	33,098	57,906	Positive News
VERA Vera Therapeutics	$38.64 -3.4%	N/A	$2.12 billion	433,759	904,131
GLPG Galapagos	$29.74 -1.8%	N/A	$1.96 billion	174,486	131,561	News Coverage
BEAM Beam Therapeutics	$23.26 -0.6%	N/A	$1.91 billion	524,233	1.24 million
NVAX Novavax	$13.04 +0.2%	N/A	$1.83 billion	3.48 million	10.24 million
ARVN Arvinas	$25.78 +1.9%	N/A	$1.76 billion	666,734	730,894
FTRE Fortrea	$18.67 +1.2%	N/A	$1.67 billion	1.03 million	1.29 million	Analyst Forecast News Coverage
BCRX BioCryst Pharmaceuticals	$7.20 -3.2%	N/A	$1.54 billion	1.58 million	3.05 million	News Coverage
RXRX Recursion Pharmaceuticals	$6.44 +4.2%	N/A	$1.53 billion	3.77 million	5.83 million
IMCR Immunocore	$30.57 -0.6%	N/A	$1.53 billion	363,023	559,222	Analyst Downgrade News Coverage
RCKT Rocket Pharmaceuticals	$17.25 +2.9%	N/A	$1.52 billion	843,324	791,051
VRDN Viridian Therapeutics	$23.40 +0.6%	N/A	$1.49 billion	593,278	1.14 million
TPC Tutor Perini	$26.44 -1.6%	N/A	$1.38 billion	409,540	452,469	Gap Up
OCSL Oaktree Specialty Lending	$16.40 +0.4%	12.24	$1.33 billion	522,645	675,296
SAVA Cassava Sciences	$26.05 +2.5%	N/A	$1.25 billion	7.20 million	1.74 million	Analyst Upgrade Gap Up High Trading Volume
PHR Phreesia	$21.36 -0.1%	N/A	$1.23 billion	324,236	457,165	News Coverage Positive News
COGT Cogent Biosciences	$10.85 +1.0%	N/A	$1.19 billion	1.11 million	1.46 million	Positive News
EVO Evotec	$3.26 -2.4%	N/A	$1.16 billion	111,140	107,164	Analyst Downgrade
TYRA Tyra Biosciences	$21.64 +3.8%	N/A	$1.14 billion	105,908	147,611	Analyst Forecast
SYRE Spyre Therapeutics	$27.88 +1.4%	N/A	$1.12 billion	312,785	518,358
TRNS Transcat	$121.06 +1.8%	76.14	$1.07 billion	40,102	76,328	Positive News
VIR Vir Biotechnology	$7.32 -1.1%	N/A	$1.00 billion	561,899	1.01 million
WVE Wave Life Sciences	$8.00 -0.5%	N/A	$979.80 million	587,160	989,074	Analyst Revision
THR Thermon Group	$28.38 -0.6%	18.92	$961.26 million	77,392	197,384
HQH Abrdn Healthcare Investors	$18.30 +0.5%	N/A	$926.44 million	100,878	160,884
SANA Sana Biotechnology	$4.08 -3.1%	N/A	$903.73 million	946,897	2.27 million	Gap Up
ANAB AnaptysBio	$32.35 -2.0%	N/A	$901.53 million	302,376	326,014
PRTA Prothena	$16.69 +0.6%	N/A	$897.46 million	393,810	600,316
ZYME Zymeworks	$12.53 +0.3%	N/A	$890.26 million	300,397	640,312	Positive News
CRGX CARGO Therapeutics	$19.02 +2.0%	N/A	$872.30 million	184,045	269,150
IGMS IGM Biosciences	$14.55 +6.0%	N/A	$858.80 million	186,139	321,639
DNTH Dianthus Therapeutics	$27.99 +5.7%	N/A	$821.48 million	454,143	194,956	High Trading Volume
SLRC SLR Investment	$15.03 -0.2%	8.44	$819.96 million	133,815	159,463
WNC Wabash National	$18.27 +1.2%	4.39	$803.88 million	315,993	597,477
REPL Replimune Group	$11.74 +3.6%	N/A	$802.08 million	809,536	1.12 million
ADPT Adaptive Biotechnologies	$5.25 -3.0%	N/A	$773.68 million	632,732	1.46 million
IMNM Immunome	$12.90 +3.6%	N/A	$773.60 million	754,201	782,679	News Coverage
TNGX Tango Therapeutics	$6.89 -1.4%	N/A	$736.17 million	539,037	747,399
TRML Tourmaline Bio	$28.49 +6.9%	N/A	$730.68 million	233,075	314,899	News Coverage
TCPC BlackRock TCP Capital	$8.07 -2.2%	23.06	$703.56 million	544,283	766,523
RAPP Rapport Therapeutics	$19.71 -6.3%	N/A	$697.26 million	93,535	182,473	Positive News
JTEK JPMorgan U.S. Tech Leaders ETF	$69.50 +1.5%	47.95	$681.10 million	48,550	72,522
LAB Standard BioTools	$1.80 -1.1%	N/A	$666.76 million	886,444	2.52 million	Positive News
CDMO Avid Bioservices	$10.35 -1.2%	N/A	$658.06 million	215,101	1.12 million	Positive News
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now
NGNE Neurogene	$50.32 +5.9%	N/A	$653.15 million	150,228	120,328
TRDA Entrada Therapeutics	$16.39 -0.9%	26.02	$635 million	93,016	162,368
CAPR Capricor Therapeutics	$19.33 +6.9%	N/A	$618.15 million	4.30 million	1.04 million	High Trading Volume
SLP Simulations Plus	$30.19 +1.2%	62.90	$604.04 million	94,426	122,667
SLN Silence Therapeutics	$19.45 +4.5%	N/A	$582.10 million	123,323	207,053	Analyst Forecast News Coverage
ABVX ABIVAX Société Anonyme	$9.13 -4.6%	N/A	$574.54 million	282,109	85,146	High Trading Volume
ALGS Aligos Therapeutics	$7.32 -2.4%	N/A	$571.77 million	69,605	29,619	High Trading Volume
RVNC Revance Therapeutics	$5.22 -2.1%	N/A	$545.22 million	1.25 million	2.84 million
CELC Celcuity	$15.26 -0.1%	N/A	$535.99 million	151,654	287,905	Analyst Forecast News Coverage
QTTB Q32 Bio	$44.79 +3.2%	N/A	$534.88 million	70,943	65,432

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

(Ad)

The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists:

Low Priced Stocks:

Stocks By Exchange:

Latest Stock Ideas:

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools